PubMed:24498956 / 190-393
Annnotations
GlyCosmos600-CLO
{"project":"GlyCosmos600-CLO","denotations":[{"id":"T3","span":{"begin":92,"end":96},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"False-negative results for the conventional marker CA125 frequently occur in cases of clear cell carcinoma (CCC), a type of EOC; therefore, it is necessary to develop biomarkers with greater sensitivity."}
Allie
{"project":"Allie","denotations":[{"id":"SS1_24498956_2_0","span":{"begin":86,"end":106},"obj":"expanded"},{"id":"SS2_24498956_2_0","span":{"begin":108,"end":111},"obj":"abbr"}],"relations":[{"id":"AE1_24498956_2_0","pred":"abbreviatedTo","subj":"SS1_24498956_2_0","obj":"SS2_24498956_2_0"}],"text":"False-negative results for the conventional marker CA125 frequently occur in cases of clear cell carcinoma (CCC), a type of EOC; therefore, it is necessary to develop biomarkers with greater sensitivity."}
GlyCosmos600-FMA
{"project":"GlyCosmos600-FMA","denotations":[{"id":"T2","span":{"begin":92,"end":96},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"False-negative results for the conventional marker CA125 frequently occur in cases of clear cell carcinoma (CCC), a type of EOC; therefore, it is necessary to develop biomarkers with greater sensitivity."}
sentences
{"project":"sentences","denotations":[{"id":"TextSentencer_T3","span":{"begin":0,"end":203},"obj":"Sentence"},{"id":"T3","span":{"begin":0,"end":203},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"False-negative results for the conventional marker CA125 frequently occur in cases of clear cell carcinoma (CCC), a type of EOC; therefore, it is necessary to develop biomarkers with greater sensitivity."}
pubmed-enju-pas
{"project":"pubmed-enju-pas","denotations":[{"id":"EnjuParser_T29","span":{"begin":0,"end":14},"obj":"JJ"},{"id":"EnjuParser_T30","span":{"begin":15,"end":22},"obj":"NNS"},{"id":"EnjuParser_T31","span":{"begin":23,"end":26},"obj":"IN"},{"id":"EnjuParser_T32","span":{"begin":27,"end":30},"obj":"DT"},{"id":"EnjuParser_T33","span":{"begin":31,"end":43},"obj":"JJ"},{"id":"EnjuParser_T34","span":{"begin":44,"end":50},"obj":"NN"},{"id":"EnjuParser_T35","span":{"begin":51,"end":56},"obj":"NN"},{"id":"EnjuParser_T36","span":{"begin":57,"end":67},"obj":"RB"},{"id":"EnjuParser_T37","span":{"begin":68,"end":73},"obj":"VBP"},{"id":"EnjuParser_T38","span":{"begin":74,"end":76},"obj":"IN"},{"id":"EnjuParser_T39","span":{"begin":77,"end":82},"obj":"NNS"},{"id":"EnjuParser_T40","span":{"begin":83,"end":85},"obj":"IN"},{"id":"EnjuParser_T41","span":{"begin":86,"end":91},"obj":"JJ"},{"id":"EnjuParser_T42","span":{"begin":92,"end":96},"obj":"NN"},{"id":"EnjuParser_T43","span":{"begin":97,"end":106},"obj":"NN"},{"id":"EnjuParser_T44","span":{"begin":107,"end":108},"obj":"-LRB-"},{"id":"EnjuParser_T45","span":{"begin":108,"end":111},"obj":"NN"},{"id":"EnjuParser_T46","span":{"begin":111,"end":112},"obj":"-RRB-"},{"id":"EnjuParser_T47","span":{"begin":112,"end":113},"obj":"-COMMA-"},{"id":"EnjuParser_T48","span":{"begin":114,"end":115},"obj":"DT"},{"id":"EnjuParser_T49","span":{"begin":116,"end":120},"obj":"NN"},{"id":"EnjuParser_T50","span":{"begin":121,"end":123},"obj":"IN"},{"id":"EnjuParser_T51","span":{"begin":124,"end":127},"obj":"NN"},{"id":"EnjuParser_T52","span":{"begin":127,"end":128},"obj":"-SEMICOLON-"},{"id":"EnjuParser_T53","span":{"begin":129,"end":138},"obj":"RB"},{"id":"EnjuParser_T54","span":{"begin":138,"end":139},"obj":"-COMMA-"},{"id":"EnjuParser_T55","span":{"begin":140,"end":142},"obj":"PRP"},{"id":"EnjuParser_T56","span":{"begin":143,"end":145},"obj":"VBZ"},{"id":"EnjuParser_T57","span":{"begin":146,"end":155},"obj":"JJ"},{"id":"EnjuParser_T58","span":{"begin":156,"end":158},"obj":"TO"},{"id":"EnjuParser_T59","span":{"begin":159,"end":166},"obj":"VB"},{"id":"EnjuParser_T60","span":{"begin":167,"end":177},"obj":"NNS"},{"id":"EnjuParser_T61","span":{"begin":178,"end":182},"obj":"IN"},{"id":"EnjuParser_T62","span":{"begin":183,"end":190},"obj":"JJR"},{"id":"EnjuParser_T63","span":{"begin":191,"end":202},"obj":"NN"}],"relations":[{"id":"EnjuParser_R29","pred":"arg1Of","subj":"EnjuParser_T30","obj":"EnjuParser_T29"},{"id":"EnjuParser_R30","pred":"arg1Of","subj":"EnjuParser_T30","obj":"EnjuParser_T31"},{"id":"EnjuParser_R31","pred":"arg2Of","subj":"EnjuParser_T35","obj":"EnjuParser_T31"},{"id":"EnjuParser_R32","pred":"arg1Of","subj":"EnjuParser_T35","obj":"EnjuParser_T32"},{"id":"EnjuParser_R33","pred":"arg1Of","subj":"EnjuParser_T35","obj":"EnjuParser_T33"},{"id":"EnjuParser_R34","pred":"arg1Of","subj":"EnjuParser_T35","obj":"EnjuParser_T34"},{"id":"EnjuParser_R35","pred":"arg1Of","subj":"EnjuParser_T37","obj":"EnjuParser_T36"},{"id":"EnjuParser_R36","pred":"arg1Of","subj":"EnjuParser_T30","obj":"EnjuParser_T37"},{"id":"EnjuParser_R37","pred":"arg1Of","subj":"EnjuParser_T37","obj":"EnjuParser_T38"},{"id":"EnjuParser_R38","pred":"arg2Of","subj":"EnjuParser_T39","obj":"EnjuParser_T38"},{"id":"EnjuParser_R39","pred":"arg1Of","subj":"EnjuParser_T39","obj":"EnjuParser_T40"},{"id":"EnjuParser_R40","pred":"arg2Of","subj":"EnjuParser_T43","obj":"EnjuParser_T40"},{"id":"EnjuParser_R41","pred":"arg1Of","subj":"EnjuParser_T43","obj":"EnjuParser_T41"},{"id":"EnjuParser_R42","pred":"arg1Of","subj":"EnjuParser_T43","obj":"EnjuParser_T42"},{"id":"EnjuParser_R43","pred":"arg1Of","subj":"EnjuParser_T43","obj":"EnjuParser_T44"},{"id":"EnjuParser_R44","pred":"arg2Of","subj":"EnjuParser_T45","obj":"EnjuParser_T44"},{"id":"EnjuParser_R45","pred":"arg3Of","subj":"EnjuParser_T46","obj":"EnjuParser_T44"},{"id":"EnjuParser_R46","pred":"arg1Of","subj":"EnjuParser_T39","obj":"EnjuParser_T47"},{"id":"EnjuParser_R47","pred":"arg2Of","subj":"EnjuParser_T49","obj":"EnjuParser_T47"},{"id":"EnjuParser_R48","pred":"arg1Of","subj":"EnjuParser_T49","obj":"EnjuParser_T48"},{"id":"EnjuParser_R49","pred":"arg1Of","subj":"EnjuParser_T49","obj":"EnjuParser_T50"},{"id":"EnjuParser_R50","pred":"arg2Of","subj":"EnjuParser_T51","obj":"EnjuParser_T50"},{"id":"EnjuParser_R51","pred":"arg1Of","subj":"EnjuParser_T37","obj":"EnjuParser_T52"},{"id":"EnjuParser_R52","pred":"arg2Of","subj":"EnjuParser_T56","obj":"EnjuParser_T52"},{"id":"EnjuParser_R53","pred":"arg1Of","subj":"EnjuParser_T56","obj":"EnjuParser_T53"},{"id":"EnjuParser_R54","pred":"arg1Of","subj":"EnjuParser_T56","obj":"EnjuParser_T54"},{"id":"EnjuParser_R55","pred":"arg1Of","subj":"EnjuParser_T59","obj":"EnjuParser_T55"},{"id":"EnjuParser_R56","pred":"arg1Of","subj":"EnjuParser_T59","obj":"EnjuParser_T56"},{"id":"EnjuParser_R57","pred":"arg2Of","subj":"EnjuParser_T57","obj":"EnjuParser_T56"},{"id":"EnjuParser_R58","pred":"arg1Of","subj":"EnjuParser_T59","obj":"EnjuParser_T57"},{"id":"EnjuParser_R59","pred":"arg1Of","subj":"EnjuParser_T59","obj":"EnjuParser_T58"},{"id":"EnjuParser_R60","pred":"arg2Of","subj":"EnjuParser_T60","obj":"EnjuParser_T59"},{"id":"EnjuParser_R61","pred":"arg1Of","subj":"EnjuParser_T59","obj":"EnjuParser_T61"},{"id":"EnjuParser_R62","pred":"arg2Of","subj":"EnjuParser_T63","obj":"EnjuParser_T61"},{"id":"EnjuParser_R63","pred":"arg1Of","subj":"EnjuParser_T63","obj":"EnjuParser_T62"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"False-negative results for the conventional marker CA125 frequently occur in cases of clear cell carcinoma (CCC), a type of EOC; therefore, it is necessary to develop biomarkers with greater sensitivity."}
mondo_disease
{"project":"mondo_disease","denotations":[{"id":"T5","span":{"begin":86,"end":106},"obj":"Disease"},{"id":"T6","span":{"begin":108,"end":111},"obj":"Disease"},{"id":"T7","span":{"begin":124,"end":127},"obj":"Disease"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005004"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005004"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0018364"}],"text":"False-negative results for the conventional marker CA125 frequently occur in cases of clear cell carcinoma (CCC), a type of EOC; therefore, it is necessary to develop biomarkers with greater sensitivity."}
GlyCosmos15-HP
{"project":"GlyCosmos15-HP","denotations":[{"id":"T4","span":{"begin":97,"end":106},"obj":"Phenotype"},{"id":"T5","span":{"begin":108,"end":111},"obj":"Phenotype"}],"attributes":[{"id":"A4","pred":"hp_id","subj":"T4","obj":"HP:0030731"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"HP:0030731"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"False-negative results for the conventional marker CA125 frequently occur in cases of clear cell carcinoma (CCC), a type of EOC; therefore, it is necessary to develop biomarkers with greater sensitivity."}